Developing a universal vaccine for influenza
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities
This study is looking at how flu viruses change and spread, and how our immune system fights them, so we can find better ways to protect everyone with vaccines, including a universal flu shot that works for a longer time.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Georgia NIH-funded |
| Lab location | 1 site (Athens, United States) |
| Project ID | NIH-11070186 on NIH RePORTER |
What this research studies
This research focuses on understanding the factors that influence how influenza viruses evolve and spread, as well as how the immune system responds to these infections. By conducting cohort studies and sampling from both humans and animals, the research aims to identify key immunological factors that can lead to better protection against influenza. The ultimate goal is to improve vaccination strategies and develop a universal influenza vaccine that offers broader and longer-lasting immunity.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who are at high risk for influenza, such as the elderly, young children, and those with compromised immune systems.
Not a fit: Patients who are not at risk for influenza or who have already received effective vaccination may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of a universal influenza vaccine that provides enhanced protection against various strains of the virus.
How similar studies have performed: Previous research has shown promise in developing universal vaccines for influenza, indicating that this approach has potential for success.
Where this research is happening
Athens, United States
- University of Georgia — Athens, United States (Active)
Researchers
- Principal investigator: Tompkins, S. Mark — University of Georgia
- Study coordinator: Tompkins, S. Mark
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.